Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Meet the diagnostic criteria for new diagnosis of T2D in Western medicine; ? Meet the diagnostic criteria for stomach and intestines heat syndrome in Chinese medicine; ? Age =18 and =65; ? Voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: ?Those who have obvious acute and chronic complications related to diabetes mellitus and are not suitable to participate in the study as assessed by clinicians, including but not limited to acute complications of diabetes mellitus (diabetic ketoacidosis, hyperosmolar hyperglycemia syndrome, lactic acidosis), diabetic renal disease, diabetic peripheral neuropathy, diabetic ophthalmopathy, and diabetic foot; ? Combined with severe cardiovascular, cerebrovascular and other diseases, assessed by the clinician is not suitable for participation in this study, including but not limited to very high-risk hypertension, unstable angina pectoris, myocardial infarction, stroke, malignant tumors and so on; ? Patients with psychiatric disorders such as bipolar disorder, schizophrenia, etc. in combination; ? Patients with impaired liver and kidney functions: serum transaminases greater than two times the normal value, serum creatinine greater than the upper limit of normal value; ? Those who have experienced allergy to an ingredient of the Chinese medicine compound used in the study; ? Females of childbearing age who have recent reproductive needs; ? Those who have recent need for surgery and may interrupt the treatment program; ?Those who are participating in or have participated in other clinical studies within the past month; ? Subjects with chronic alcoholism and other adverse personal habits, and poor compliance, which, in the judgment of the investigators, may potentially affect the results of the study; ? Those who, in the judgment of the investigator, may have difficulties in follow-up or other complications after enrollment of the subject, including but not limited to unstable place of residence, frequent changes in work environment, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fasting glucose; | — |
Secondary
| Measure | Time frame |
|---|---|
| 2h postprandial blood glucose;HbA1c;glycosylated albumin (GAL); | — |
Countries
CHINA
Contacts
Hospital of Chengdu University of Traditional Chinese Medicine